Follistatin-Like 1 Promotes Bleomycin-Induced Pulmonary Fibrosis Through the Transforming Growth Factor Beta 1/Mitogen-Activated Protein Kinase Signaling Pathway (vol 131, pg 1917, 2018)

被引：0
|
作者：
Jin, Y. K.
Li, X. H.
Wang, W.
Liu, J.
Zhang, W.
Fang, Y. S.
Zhang, Z. F.
Dai, H. P.
Ning, W.
Wang, C.
机构：
来源：
CHINESE MEDICAL JOURNAL | 2020年 / 133卷 / 14期
关键词：
D O I：
10.1097/CM9.0000000000000952
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：1764 / 1764
页数：1
相关论文
共 50 条
  • [1] Follistatin-Like 1 Promotes Bleomycin-Induced Pulmonary Fibrosis through the Transforming Growth Factor Beta 1/Mitogen-Activated Protein Kinase Signaling Pathway
    Jin, Yan-Kun
    Li, Xiao-He
    Wang, Wang
    Liu, Jie
    Zhang, Wei
    Fang, Yin-Shan
    Zhang, Zhi-Fei
    Dai, Hua-Ping
    Ning, Wen
    Wang, Chen
    CHINESE MEDICAL JOURNAL, 2018, 131 (16) : 1917 - 1925
  • [2] Follistatin-Like 1 Promotes Bleomycin-Induced Pulmonary Fibrosis through the Transforming Growth Factor Beta 1/Mitogen-Activated Protein Kinase Signaling Pathway
    Jin YanKun
    Li XiaoHe
    Wang Wang
    Liu Jie
    Zhang Wei
    Fang YinShan
    Zhang ZhiFei
    Dai HuaPing
    Ning Wen
    Wang Chen
    Department of Respiratory and Critical Care Medicine Beijing ChaoYang Hospital Capital Medical University Beijing China
    Department of Respiratory Disease Beijing Key Laboratory of Respiratory and Pulmonary Circulation Disorders Capital Medical University Beijing China
    Department of Respiratory Disease Capital Medical University Beijing China
    Department of Life Sciences State Key Laboratory of Medicinal Chemical Biology College of Life Sciences Nankai University Tianjin China
    Department of Respiratory Disease Beijing Key Laboratory of Respiratory and Pulmonary Circulation Disorders Capital Medical University Beijing China
    Department of Physiology and Pathophysiology Capital Medical University Beijing China
    Department of Respiratory Disease Capital Medical University Beijing China
    中华医学杂志英文版, 2018, 131 (16) : 1917 - 1925
  • [3] Corrigendum: Follistatin-Like 1 Promotes Bleomycin-Induced Pulmonary Fibrosis Through the Transforming Growth Factor Beta 1/Mitogen-Activated Protein Kinase Signaling Pathway
    中华医学杂志(英文版), 2020, (14) : 1764 - 1764
  • [4] FLUOROFENIDONE ATTENUATES BLEOMYCIN-INDUCED PULMONARY INFLAMMATION AND FIBROSIS IN MICE VIA RESTORING CAVEOLIN 1 EXPRESSION AND INHIBITING MITOGEN-ACTIVATED PROTEIN KINASE SIGNALING PATHWAY
    Meng, Jie
    Zou, Yeqiang
    Hu, Chengping
    Zhu, Yuxian
    Peng, Zhangzhe
    Hu, Gaoyun
    Wang, Zhaohe
    Tao, Lijian
    SHOCK, 2012, 38 (05): : 567 - 573
  • [5] Mechanism of transforming growth factor-β1 signaling:: Role of the mitogen-activated protein kinase
    Choi, ME
    KIDNEY INTERNATIONAL, 2000, 58 : S53 - S58
  • [6] Blocking follistatin-like 1 attenuates liver fibrosis in mice by regulating transforming growth factor-beta signaling
    Zhang, Xiao-Hua
    Chen, Yong
    Li, Bin
    Liu, Ji-Yong
    Yang, Chong-Mei
    Ma, Ming-Ze
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2018, 11 (03): : 1112 - 1122
  • [7] FLUOROFENIDONE ATTENUATES BLEOMYCIN-INDUCED PULMONARYINFLAMMATION AND FIBROSIS IN MICE VIA RESTORING CAVEOLIN-1 EXPRESSION AND INHIBITING MITOGEN-ACTIVATED PROTEIN KINASE SIGNALING PATHWAY
    Meng, Jie
    Hu, Chengping
    RESPIROLOGY, 2013, 18 : 73 - 73
  • [8] LUNG TRANSFORMING GROWTH-FACTOR BETA(1), BETA(2), AND BETA(3) EXPRESSION IN BLEOMYCIN-INDUCED PULMONARY FIBROSIS
    GHARAEEKERMANI, M
    MCGARRY, B
    PHAN, S
    FASEB JOURNAL, 1995, 9 (04): : A972 - A972
  • [9] Transforming growth factor beta 1 inhibits mitogen-activated protein kinase induced by basic fibroblast growth factor in smooth muscle cells
    Berrou, E
    FontenayRoupie, M
    Quarck, R
    McKenzie, FR
    LevyToledano, S
    Tobelem, G
    Bryckaert, M
    BIOCHEMICAL JOURNAL, 1996, 316 : 167 - 173
  • [10] The role of vascular endothelial growth factor receptor 1 tyrosine kinase signaling in bleomycin-induced pulmonary fibrosis
    Amano, Hideki
    Mastui, Yoshio
    Ito, Yoshiya
    Shibata, Yusaku
    Betto, Tomohiro
    Eshima, Koji
    Ogawa, Fumihiro
    Satoh, Yukitoshi
    Shibuya, Masabumi
    Majima, Masataka
    BIOMEDICINE & PHARMACOTHERAPY, 2019, 117
12345